Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Büyüksirin (Izmir, Turkey), G. Polat (Izmir, Turkey), H. Sahin (Izmir, Turkey), A. Ayranci (Izmir, Turkey), G. Karadeniz (Izmir, Turkey), F. Güldaval (Izmir, Turkey), S. Susam (Izmir, Turkey), F. Üçsular (Izmir, Turkey), C. Anar (Izmir, Turkey), O. Süneçli (Izmir, Turkey). DOES THE BENEFIT FROM PULMONARY REHABILITATION DIFFER BETWEEN PHENOTYPES IN COPD?. 98

Member's Comments

No comment yet.

Related content which might interest you: THE NEW OPPORTUNITIES OF THE PERSONALISED PULMONARY REHABILITATION PROGRAMS IN MANAGEMENT OF COPD PATIENTS: TARGETS AND GOALS Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases Year: 2019 MAINTAINING PULMONARY REHABILITATION EFFECTS IN COPD PATIENTS AT HOME – A PROTOCOL STUDY Source: Virtual Congress 2020 – Challenges and updates in nursing care around the world Year: 2020 ARE THERE CLINICALLY RELEVANT BENEFITS IN A STRUCTURED PROGRAM OF PHYSICAL ACTIVITY IN COPD? ACTIVEPOC STUDY. Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe Year: 2020 EXTRARESPIRATORY SYMPTOM BURDEN IN PATIENTS HOSPITALIZED FOR A COPD EXACERBATION: IT’S NOT ONLY ABOUT RESPIRATORY SYMPTOMS Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019 ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN DIFFERENT PHENOTYPES OF COPD Source: International Congress 2017 – Management of asthma in different situations Year: 2017 SERUM ?-2-MICROGLOBULIN CORRELATES WITH COPD OUTCOMES AND PREDICTS FUTURE HOSPITALIZATION. Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 PULMONARY REHABILITATION EFFECT ON SYSTEMIC INFLAMMATION VALUES, APOB48, LIPIDEMIA AND CARDIOVASCULAR RISK IN PATIENTS WITH COPD Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases Year: 2019 PULMONARY REHABILITATION AFTER LUNG TRANSPLANTATION: DEVELOPMENT OF A PROTOCOL Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019 HYPERCAPNIA AND FUNCTIONAL IMPROVEMENTS DURING PULMONARY REHABILITATION. Source: Virtual Congress 2021 – Physical activity, exercise training and (tele)rehabilitation in respiratory patients Year: 2021 BACTERIAL IMMUNOTHERAPY IN COPD AND/OR BRONCHIECTASIS FREQUENT EXACERBATOR PATIENTS. A RETROSPECTIVE STUDY. Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD Year: 2018 WHAT TOOLS AND RESOURCES DO PULMONARY REHABILITATION TEAMS USE TO DELIVER EDUCATION? Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020 CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!! Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020 FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS  ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP) Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 USEFULNESS OF MIRNAS AS PREDICTORS OF LUNG CANCER IN PATIENTS WITH COPD. A PILOT SUTDY Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL PULMONARY DISEASE Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis Year: 2020 Late Breaking Abstract - RHEOLOGY AS A TOOL TO ASSESS COPD DIAGNOSIS COMPARED TO ASTHMA DIAGNOSIS, AND TO EVALUATE THE EFFICIENCY OF TREATMENTS Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 PAIN AND FRAILTY IN COPD PATIENTS: RELATIONSHIP AND IMPACT ON WELLBEING AND HEALTH STATUS Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018 RATES OF LUNG FUNCTION DECLINE DIFFERS BETWEEN COPD PHENOTYPES Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 UTILITY OF THE SIMPLIFIED PESI SCALE IN ELDERLY PATIENTS WITH ACUTE  SYMPTOMATIC PULMONARY THROMBOEMBOLISM Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020 MULTIDISCIPLINARY APPROACH IN THE EVALUATION AND MANAGEMENT OF PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA. A SINGLE CENTER EXPERIENCE. Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020